399 related articles for article (PubMed ID: 27063860)
1. Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds.
Smee DF; Evans WJ; Nicolaou KC; Tarbet EB; Day CW
Antiviral Res; 2016 Jul; 131():61-5. PubMed ID: 27063860
[TBL] [Abstract][Full Text] [Related]
2. Exploration of the anti-enterovirus activity of a series of pleconaril/pirodavir-like compounds.
Bernard A; Lacroix C; Cabiddu MG; Neyts J; Leyssen P; Pompei R
Antivir Chem Chemother; 2015 Apr; 24(2):56-61. PubMed ID: 26071135
[TBL] [Abstract][Full Text] [Related]
3. Potent inhibition of enterovirus D68 and human rhinoviruses by dipeptidyl aldehydes and α-ketoamides.
Kim Y; Kankanamalage AC; Damalanka VC; Weerawarna PM; Groutas WC; Chang KO
Antiviral Res; 2016 Jan; 125():84-91. PubMed ID: 26658373
[TBL] [Abstract][Full Text] [Related]
4. Antiviral Activity of Broad-Spectrum and Enterovirus-Specific Inhibitors against Clinical Isolates of Enterovirus D68.
Sun L; Meijer A; Froeyen M; Zhang L; Thibaut HJ; Baggen J; George S; Vernachio J; van Kuppeveld FJ; Leyssen P; Hilgenfeld R; Neyts J; Delang L
Antimicrob Agents Chemother; 2015 Dec; 59(12):7782-5. PubMed ID: 26369972
[TBL] [Abstract][Full Text] [Related]
5. Validating Enterovirus D68-2A
Musharrafieh R; Ma C; Zhang J; Hu Y; Diesing JM; Marty MT; Wang J
J Virol; 2019 Apr; 93(7):. PubMed ID: 30674624
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Efficacy of Antiviral Compounds against Enterovirus D68.
Rhoden E; Zhang M; Nix WA; Oberste MS
Antimicrob Agents Chemother; 2015 Dec; 59(12):7779-81. PubMed ID: 26149998
[TBL] [Abstract][Full Text] [Related]
7. Structure and inhibition of EV-D68, a virus that causes respiratory illness in children.
Liu Y; Sheng J; Fokine A; Meng G; Shin WH; Long F; Kuhn RJ; Kihara D; Rossmann MG
Science; 2015 Jan; 347(6217):71-4. PubMed ID: 25554786
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent antipicornavirus activity.
Barnard DL; Hubbard VD; Smee DF; Sidwell RW; Watson KG; Tucker SP; Reece PA
Antimicrob Agents Chemother; 2004 May; 48(5):1766-72. PubMed ID: 15105133
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity.
Andries K; Dewindt B; Snoeks J; Willebrords R; van Eemeren K; Stokbroekx R; Janssen PA
Antimicrob Agents Chemother; 1992 Jan; 36(1):100-7. PubMed ID: 1317142
[TBL] [Abstract][Full Text] [Related]
10. A Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68.
Ma C; Hu Y; Zhang J; Musharrafieh R; Wang J
ACS Infect Dis; 2019 Nov; 5(11):1952-1962. PubMed ID: 31532189
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Quinoline Analogues as Potent Antivirals against Enterovirus D68 (EV-D68).
Musharrafieh R; Zhang J; Tuohy P; Kitamura N; Bellampalli SS; Hu Y; Khanna R; Wang J
J Med Chem; 2019 Apr; 62(8):4074-4090. PubMed ID: 30912944
[TBL] [Abstract][Full Text] [Related]
12. Enterovirus D68 Antivirals: Past, Present, and Future.
Hu Y; Musharrafieh R; Zheng M; Wang J
ACS Infect Dis; 2020 Jul; 6(7):1572-1586. PubMed ID: 32352280
[TBL] [Abstract][Full Text] [Related]
13. Severe Respiratory Illness Associated With Rhinovirus During the Enterovirus D68 Outbreak in the United States, August 2014-November 2014.
Prill MM; Dahl RM; Midgley CM; Chern SW; Lu X; Feikin DR; Sakthivel SK; Nix WA; Watson JT; Gerber SI; Oberste MS
Clin Infect Dis; 2018 May; 66(10):1528-1534. PubMed ID: 29186347
[TBL] [Abstract][Full Text] [Related]
14. Clinical severity of pediatric respiratory illness with enterovirus D68 compared with rhinovirus or other enterovirus genotypes.
Mertz D; Alawfi A; Pernica JM; Rutherford C; Luinstra K; Smieja M
CMAJ; 2015 Nov; 187(17):1279-1284. PubMed ID: 26464137
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of an isoxazole-3-carboxamide analog of pleconaril in mouse models of Enterovirus-D68 and Coxsackie B5.
Lane TR; Fu J; Sherry B; Tarbet B; Hurst BL; Riabova O; Kazakova E; Egorova A; Clarke P; Leser JS; Frost J; Rudy M; Tyler KL; Klose T; Volobueva AS; Belyaevskaya SV; Zarubaev VV; Kuhn RJ; Makarov V; Ekins S
Antiviral Res; 2023 Aug; 216():105654. PubMed ID: 37327878
[TBL] [Abstract][Full Text] [Related]
16. Discovery and Optimization of Quinoline Analogues as Novel Potent Antivirals against Enterovirus D68.
Li X; Li Y; Fan S; Cao R; Li X; He X; Li W; Xu L; Cheng T; Li H; Zhong W
J Med Chem; 2022 Nov; 65(21):14792-14808. PubMed ID: 36254462
[TBL] [Abstract][Full Text] [Related]
17. A comparison of hospitalized children with enterovirus D68 to those with rhinovirus.
Foster CB; Coelho R; Brown PM; Wadhwa A; Dossul A; Gonzalez BE; Cardenas S; Sabella C; Kohn D; Vogel S; Yen-Lieberman B; Piedimonte G
Pediatr Pulmonol; 2017 Jun; 52(6):827-832. PubMed ID: 28135044
[TBL] [Abstract][Full Text] [Related]
18. Methyl-β-cyclodextrin inhibits EV-D68 virus entry by perturbing the accumulation of virus particles and ICAM-5 in lipid rafts.
Jiang Y; Liu S; Shen S; Guo H; Huang H; Wei W
Antiviral Res; 2020 Apr; 176():104752. PubMed ID: 32101770
[TBL] [Abstract][Full Text] [Related]
19. Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C.
Mello C; Aguayo E; Rodriguez M; Lee G; Jordan R; Cihlar T; Birkus G
Antimicrob Agents Chemother; 2014; 58(3):1546-55. PubMed ID: 24366736
[TBL] [Abstract][Full Text] [Related]
20. The capsid binder Vapendavir and the novel protease inhibitor SG85 inhibit enterovirus 71 replication.
Tijsma A; Franco D; Tucker S; Hilgenfeld R; Froeyen M; Leyssen P; Neyts J
Antimicrob Agents Chemother; 2014 Nov; 58(11):6990-2. PubMed ID: 25199773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
